LONDON, UK: Fusion Antibodies plc has entered into a commercial collaboration agreement with Eurofins Discovery, a leading provider of products and services to the drug discovery industry. Eurofins is a Eurofins Scientific SE (EUFI.PA) group company. Pursuant to the Collaboration, Fusion will provide comprehensive pre-clinical antibody development services from discovery, engineering, and critical reagent supply…